New hope for HIV-immunisation
New hope for HIV-immunisation
By Marietta Gross - Scoop Media Auckland.
Genetically engineered cells made resistant against HIV-strain Scientists have succeeded in engineering cells resistant to the HI-Virus. For the first time the cells that are responsible for the growth of the human immune system, were genetically engineered to be resistant against the most common HIV-strain. But the results will not work for every patient, report scientists from Sangamo BioSciences in New Scientist magazine.
The scientists based their work on blocking the HI-Virus from infecting cells. The virus uses the surface of a carrier protein, the CCR5, to enter human cells. Some people produce a mutated, shortened form of CCR5, which doesn’t get onto the surface of the cell.
These people display more resistance against HIV-infections and show more resistance against developing symptoms.
Researchers have now proved that it is possible to induce a similar mutation within human cells. The scientists say their findings reveal new approaches that could be used to fight HIV.
Stats NZ: Economic Impacts On New Zealand From Conflict In The Middle East – Report
Advertising Standards Authority: ASA Annual Report 2025 - Platform-Neutral Regulation Keeps Pace With Digital Advertising
Science Media Centre: Lead Pipes Banned For New Plumbing – Expert Reaction
New Zealand Young Physicists Trust: Auckland To Host The ‘World Cup Of Physics’ In 2027; Search Begins For Student-Designed Tournament Logo
Oxfam Aotearoa: Top CEO Pay Increased 20 Times Faster Than Workers’ Pay In 2025
Bill Bennett: TUANZ Report - Networks Built, Value Missing

